Identification of DTYMK and CHEK1 as therapeutic targets in LKB1 mutant non-small cell lung cancer

被引：0
|
作者：
Liu, Yan [1 ]
Cowley, Glenn S. [2 ]
Cohoon, Travis J. [1 ]
Root, David E. [2 ]
Kwok-kin, Wong [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Broad Inst, Boston, MA USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-LB-260
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-260
引用
收藏
页数：1
相关论文
共 50 条
  • [1] LKB1 as the keyregulator of non-small cell lung cancer plasticity and therapeutic response
    Science Foundation in China, 2015, (03) : 15 - 15
  • [2] Glucocorticoid mediated inhibition of LKB1 mutant non-small cell lung cancers
    Huffman, Kenneth E.
    Li, Long Shan
    Carstens, Ryan
    Park, Hyunsil
    Girard, Luc
    Avila, Kimberley
    Wei, Shuguang
    Kollipara, Rahul
    Timmons, Brenda
    Sudderth, Jessica
    Bendris, Nawal
    Kim, Jiyeon
    Villalobos, Pamela
    Fujimoto, Junya
    Schmid, Sandra
    Deberardinis, Ralph J.
    Wistuba, Ignacio
    Heymach, John
    Kittler, Ralf
    Akbay, Esra A.
    Posner, Bruce
    Wang, Yuzhuo
    Lam, Stephen
    Kliewer, Steven A.
    Mangelsdorf, David J.
    Minna, John D.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] MiR-195 suppresses non-small cell lung cancer by targeting CHEK1
    Liu, Ben
    Qu, Jinli
    Xu, Fangxiu
    Guo, Yan
    Wang, Yu
    Yu, Herbert
    Qian, Biyun
    ONCOTARGET, 2015, 6 (11) : 9445 - 9456
  • [4] Phenformin enhances the therapeutic effect of selumetinib in KRAS-mutant non-small cell lung cancer irrespective of LKB1 status
    Zhang, Jun
    Nannapaneni, Sreenivas
    Wang, Dongsheng
    Liu, Fakeng
    Wang, Xu
    Jin, Rui
    Liu, Xiuju
    Rahman, Mohammad Aminur
    Peng, Xianghong
    Qian, Guoqing
    Chen, Zhuo G.
    Wong, Kwok-Kin
    Khuri, Fadlo R.
    Zhou, Wei
    Shin, Dong M.
    ONCOTARGET, 2017, 8 (35) : 59008 - 59022
  • [5] Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non-Small Cell Lung Cancer
    Wang, Yifan
    Li, Nan
    Jiang, Wen
    Deng, Weiye
    Ye, Rui
    Xu, Cai
    Qiao, Yawei
    Sharma, Amrish
    Zhang, Ming
    Hung, Mien-Chie
    Lin, Steven H.
    CLINICAL CANCER RESEARCH, 2018, 24 (22) : 5744 - 5756
  • [6] LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin
    Shackelford, David B.
    Abt, Evan
    Gerken, Laurie
    Vasquez, Debbie S.
    Seki, Atsuko
    Leblanc, Mathias
    Wei, Liu
    Fishbein, Michael C.
    Czernin, Johannes
    Mischel, Paul S.
    Shaw, Reuben J.
    CANCER CELL, 2013, 23 (02) : 143 - 158
  • [7] LKB1 deficiency is associated with a unique metabolic signature in Kras mutant non-small cell lung cancer (NSCLC)
    Liu, Tingyu
    Sennott, Erin
    Zhong, Zhengjie
    Steadman, Mya
    Marsh, Kelly
    Hurov, Jonathan
    Benes, Cyril
    Engelman, Jeffrey A.
    CANCER RESEARCH, 2016, 76
  • [8] Identifying therapy responsive and resistant LKB1 mutant non-small cell lung tumor populations
    Abt, Evan
    Momcilovic, Milica
    Seki, Atsuko
    McMickle, Robert
    Stout, David
    Fishbein, Michael C.
    Shackelford, David B.
    CANCER RESEARCH, 2014, 74 (19)
  • [9] LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response
    Li, Fuming
    Han, Xiangkun
    Li, Fei
    Wang, Rui
    Wang, Hui
    Gao, Yijun
    Wang, Xujun
    Fang, Zhaoyuan
    Zhang, Wenjing
    Yao, Shun
    Tong, Xinyuan
    Wang, Yuetong
    Feng, Yan
    Sun, Yihua
    Li, Yuan
    Wong, Kwok-Kin
    Zhai, Qiwei
    Chen, Haiquan
    Ji, Hongbin
    CANCER CELL, 2015, 27 (05) : 698 - 711
  • [10] LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-Small Cell Lung Cancer Plasticity and Therapeutic Response
    Li, Fuming
    Han, Xiangkun
    Li, Fei
    Wang, Rui
    Li, Yuan
    Wong, Kowk-Kin
    Chen, Haiquan
    Ji, Hongbin
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S473 - S474
12345